Notably, the analysis of HAS3, ABCC5, SOX2 and CD133 tumor mRNA transcripts showed that Pa + 4Mu combination therapy significantly downregulated gene expression, as was observed in the previous in vitro assays (p < 0.01; Fig. 5D). This evidence concerns the gene SOX2 and neoplasm.